ITCSX
Price
$27.19
Change
+$0.03 (+0.11%)
Updated
Dec 3 closing price
Net Assets
7.01B
RLBEX
Price
$39.78
Change
+$0.11 (+0.28%)
Updated
Dec 3 closing price
Net Assets
269.37B
Interact to see
Advertisement

ITCSX vs RLBEX

Header iconITCSX vs RLBEX Comparison
Open Charts ITCSX vs RLBEXBanner chart's image
VY® T. Rowe Price Capital Apprec S
Price$27.19
Change+$0.03 (+0.11%)
VolumeN/A
Net Assets7.01B
American Funds American Balanced R4
Price$39.78
Change+$0.11 (+0.28%)
VolumeN/A
Net Assets269.37B
ITCSX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
ITCSX vs. RLBEX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCSX is a Buy and RLBEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 269B vs. ITCSX (7.01B). ITCSX pays higher dividends than RLBEX: ITCSX (2.38) vs RLBEX (1.68). ITCSX was incepted earlier than RLBEX: ITCSX (37 years) vs RLBEX (23 years). ITCSX (0.90) is less costly to investors than RLBEX (0.59). ITCSX is a more actively managed with annual turnover of: 84.00 vs. RLBEX (44.00). ITCSX has a lower initial minimum investment than RLBEX: ITCSX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 9.28 vs. ITCSX (-5.36). RLBEX return over 5 years is better than : 39.06 vs. ITCSX (-6.33).
ITCSXRLBEXITCSX / RLBEX
Total Expense Ratio0.900.59153%
Annual Report Gross Expense Ratio0.900.59153%
Fund Existence37 years23 years-
Gain YTD-3.28516.574-20%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets7.01B269B3%
Annual Yield % from dividends2.381.68142%
Returns for 1 year-5.369.28-58%
Returns for 3 years11.1940.1928%
Returns for 5 years-6.3339.06-16%
Returns for 10 years18.5276.6724%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRSIX17.93N/A
N/A
Franklin Small-Mid Cap Growth C
TIEIX47.75N/A
N/A
Nuveen Equity Index R6
IGMIX10.73N/A
N/A
Voya Global Insights Portfolio I
EMPTX10.34N/A
N/A
UBS Emerging Markets Equity Opp P2
SNORX38.82N/A
N/A
Easterly Snow Long/Short Opportunity R6